Lancaster, NY, United States of America

Nikolaos Biris

This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Albert Einstein College of Medicine. Active years: 2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Nikolaos Biris. Retrieved from https://idiyas.com/inventor/nikolaos-biris

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Nikolaos Biris: Innovator in Mitofusin Activators

Introduction

Nikolaos Biris is a prominent inventor based in Lancaster, NY (US). He has made significant contributions to the field of medical research, particularly in the development of mitofusin activators. His work focuses on the treatment of various diseases and disorders, showcasing his commitment to advancing healthcare.

Latest Patents

Nikolaos Biris holds 1 patent for his invention titled "Mitofusin activators and uses thereof." This patent discloses activators of mitofusins and their applications in treating diseases and disorders. His innovative approach has the potential to impact therapeutic strategies significantly.

Career Highlights

Biris is affiliated with the Albert Einstein College of Medicine, where he conducts research and collaborates with other experts in the field. His role at this esteemed institution allows him to contribute to groundbreaking studies and advancements in medical science.

Collaborations

Some of his notable coworkers include Evripidis Gavathiotis and Richard N Kitsis. Their collaborative efforts enhance the research environment and foster innovation in their respective fields.

Conclusion

Nikolaos Biris is a dedicated inventor whose work on mitofusin activators represents a significant advancement in medical research. His contributions are poised to make a lasting impact on the treatment of various diseases and disorders.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…